| 000 | 01142 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514000048.0 | ||
| 264 | 0 | _c20020919 | |
| 008 | 200209s 0 0 eng d | ||
| 022 | _a1465-6566 | ||
| 024 | 7 |
_a10.1517/14656566.2.3.385 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGriesshammer, M | |
| 245 | 0 | 0 |
_aCurrent treatment practice for essential thrombocythaemia in adults. _h[electronic resource] |
| 260 |
_bExpert opinion on pharmacotherapy _cMar 2001 |
||
| 300 |
_a385-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAspirin _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxyurea _xtherapeutic use |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 |
_aPipobroman _xtherapeutic use |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aQuinazolines _xtherapeutic use |
| 650 | 0 | 4 |
_aThrombocythemia, Essential _xdiagnosis |
| 700 | 1 | _aBangerter, M | |
| 700 | 1 | _aGrünewald, M | |
| 773 | 0 |
_tExpert opinion on pharmacotherapy _gvol. 2 _gno. 3 _gp. 385-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14656566.2.3.385 _zAvailable from publisher's website |
| 999 |
_c11269700 _d11269700 |
||